CASC9 and neoplasm: Both CASC9 and LUCAT1 were produced from the exosomes, and a high CASC9 level was correlated with tumor growth and postoperative HCC recurrence, implying its potential application as a non-invasive predictive biomarker for HCC recurrence.29